Maria is a 38-year-old woman with a history of severe Alcoho…
Maria is a 38-year-old woman with a history of severe Alcohol Use Disorder. She recently completed detoxification and expresses strong motivation to remain abstinent. She has no significant medical comorbidities and is open to pharmacological support as part of her relapse prevention plan. She reports that she has intense cravings, especially during the evenings, but no ongoing liver disease or opioid use. She is not currently on any medications. Which of the following is the most appropriate pharmacological agent to help Maria maintain abstinence from alcohol?